Basit öğe kaydını göster

dc.contributor.authorGuzel, Savas
dc.contributor.authorYilmaz, Murat
dc.contributor.authorTasdemir, Nicel
dc.contributor.authorAksu, Erson
dc.contributor.authorCelik, Cem
dc.contributor.authorYuksel, Aytac
dc.contributor.authorAbali, Remzi
dc.date.accessioned2021-03-06T08:33:10Z
dc.date.available2021-03-06T08:33:10Z
dc.date.issued2012
dc.identifier.citationCelik C., Abali R., Tasdemir N., Guzel S., Yuksel A., Aksu E., Yilmaz M., "Is subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome?", GYNECOLOGICAL ENDOCRINOLOGY, cilt.28, ss.615-618, 2012
dc.identifier.issn0951-3590
dc.identifier.otherav_e18460b6-51cf-452f-93e6-7c7e8759cc51
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/148459
dc.identifier.urihttps://doi.org/10.3109/09513590.2011.650765
dc.description.abstractWe aimed to analyze lipid parameters and determine the need for a 2-hour oral glucose tolerance test (OGTT) for the identification of IR and impaired glucose tolerance test (IGT) in subclinical hypothyroidism (SCH) women with and without polycystic ovary syndrome (PCOS). 20 patients with PCOS and SCH consisted of Group I and 39 patients with PCOS and normal thyroid function consisted of Group II and 53 healthy women with normal thyroid function consisted of Group III. Triglyceride levels were 143.26 +/- 99.86 mg/dL in group 1 and 88.56 +/- 37.56 mg/dL in group 2 and 83.71 +/- 31.94 mg/dL in group 3 which were statistically significant. Total cholesterol, HDL-cholesterol, LDL-cholesterol were found similar between the groups. Fasting insulin levels were 12.45 +/- 8.62 mu U/mL in group 1 and 8.60 +/- 5.35 mu U/mL in group 2 and 7.04 +/- 3.55 mu U/mL in group 3 which were statistically significant (P = 0.027). HOMA-IR were 2.92 +/- 2.34 in group 1 and 1.95 +/- 1.52 in group 2 and 1.60 +/- 0.86 in group 3 which were statistically significant (P = 0.046). This study showed that women with PCOS and subclinical hypothyroidism should be evaluated for dyslipidemia and Insulin resistance.
dc.language.isoeng
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectCerrahi Tıp Bilimleri
dc.subjectKadın Hastalıkları ve Doğum
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKADIN HASTALIKLARI & DOĞUM
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.titleIs subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome?
dc.typeMakale
dc.relation.journalGYNECOLOGICAL ENDOCRINOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume28
dc.identifier.issue8
dc.identifier.startpage615
dc.identifier.endpage618
dc.contributor.firstauthorID205214


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster